Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.01 | 1.4 |
NAV | ₹31.12 | ₹1901.79 |
Fund Started | 10 Jun 2020 | 08 Dec 1994 |
Fund Size | ₹1962.03 Cr | ₹69639.05 Cr |
Exit Load | Exit load of 1%, if redeemed within 3 months. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -2.29% | 15.91% |
3 Year | 19.43% | 24.21% |
5 Year | - | 31.64% |
1 Year
3 Year
5 Year
Equity | 99.16% | 87.39% |
Cash | 0.69% | 11.01% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
State Bank of India | 5.15% |
HDFC Bank Ltd. | 4.89% |
Vedanta Ltd. | 4.77% |
Coforge Ltd. | 3.99% |
Lloyds Metals & Energy Ltd. | 3.81% |
Hindustan Aeronautics Ltd. | 3.32% |
ICICI Bank Ltd. | 3.02% |
REC Ltd. | 2.98% |
NTPC Green Energy Ltd. | 2.67% |
Bharti Airtel Ltd. | 2.30% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.58% |
HDFC Bank Ltd. | 9.45% |
Axis Bank Ltd. | 8.86% |
Kotak Mahindra Bank Ltd. | 5.14% |
SBI Life Insurance Company Ltd. | 4.33% |
Maruti Suzuki India Ltd. | 4.14% |
Cipla Ltd. | 3.98% |
Bharti Airtel Ltd. | 3.19% |
HCL Technologies Ltd. | 2.74% |
Piramal Pharma Ltd. | 2.62% |
Name | Alok Singh | Dhruv Muchhal |
Start Date | 01 Dec 2021 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity-related securities across various market capitalisation. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 10 Jun 2020 | 08 Dec 1994 |
Description
Launch Date